Macro Group Pharmaceutical S.A.E. (MCRO) Key Statistics
18 reported figures for Macro Group Pharmaceutical S.A.E. — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 5.84B
- Dividend yield
- 0%
Income (latest fiscal year)
- Revenue
- EGP 526.01M
- Net income
- EGP -272.65M
- EBITDA
- EGP -165.1M
- Free cash flow
- EGP -42.46M
Balance sheet
- Total assets
- EGP 513.69M
- Total debt
- EGP 226.18M
Growth
- Revenue growth
- -27.91%
- Profit growth
- -256.84%
- EPS growth
- -259.13%
Per share
- EPS (fiscal year)
- -0.11
- Dividend per share
- 0
Technical
- RSI (14)
- 65.5
- 50-day moving average
- EGP 1.47
- 200-day moving average
- EGP 1.29
- Beta (1Y)
- 0.52
Shares
- Shares outstanding
- 3.42B
Source: company disclosures to the Egyptian Exchange via TradingView. Fiscal-year figures are as last reported; technical readings refresh with market data.